ESG Implementation Framework
ESG Management Vision & Strategies
Under SK bioscience’s mission of ‘Promoting human health, from prevention to cure’, we established an ESG implementation framework and specific tasks for each area centered around our ESG vision of ‘Healthier Life, Sustainable Future’. We will secure the momentum for sustainable growth by managing environmental and social risks and realizing transparency in governance.
ESG Vision
Healthier Life, Sustainable Future
Category | ESG Strategic Direction | ESG Strategic Goals | Key Achievements (2021~2024) | Short-term Goals (2025) | Mid- to Long-term Goals (~ 2035) |
---|---|---|---|---|---|
E |
![]() Strengthening Eco-friendly Management Systems |
|
|
|
|
|
|
|
|
||
S |
![]() Pursuing Stakeholders Happiness |
|
|
|
|
|
|
|
|
||
![]() Creating SV linked to Business Activities |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
||
G |
![]() Implementing Sustainable & Transparent Governance |
|
|
|
|
|
|
|
|
ESG Management Process


- ESG 경영
- ESG 전략
- ESG 활동
- 정보공개
- 평가대응
ESG Management Governance
SK bioscience established an ESG Management Implementation Governance to elevate its ESG management to the level of a global leading company. This governance is designed to manage non-financial risks and create new business opportunities effectively. For systematic ESG management, it comprises the ESG Committee, ESG Working-level Council, and ESG team. The ESG Committee under the Board serves as the highest deliberation and decision-making body for ESG management. On the other hand, the ESG Working-level Council is responsible for implementing ESG improvement tasks and creating tangible outcomes. Based on short and mid- to long-term improvement tasks aligned with ESG, ESG team is in charge of company-wide projects, including reporting management-level meetings, decision-making support. It also handles reporting/disclosure and responds to external rating agencies.


-
이사회 보고:2가지 기능
- Board of Directors
- ESG위원회
-
경영층 회의체 : 비재무적 리스크 관리
- ESG위원회 사무국(ES팀)
-
실무 회의체 : 사업 연계 신규기회 창출 등
- ESG 협의체
- ESG 실무협의체
-
ESG 전략 방향에 따른 실무조직
- 친환경 경영체계 구축:SHE/CS/운영지원
- 이해관계자 행복추구:HR/TM/ESG
- 업(業) 연계 사회적 가치 창출:전략기획/BD/마케팅/구매
- 지속가능하고 투명한 거버넌스 운영:대외협력/IR/법무/윤리경영
Social Value Creation
Outcomes of Social Value Creation
SK bioscience provides visible metrics and benchmarks to measure the social value we create. The main measurement areas are indirect economic contributions, environmental performance, and social performance. We embed social value into every process of creating and delivering our products and services. We objectively measure and manage the positive impacts of this value on our society. Additionally, by disclosing our social value measurement formulas, we aim to communicate with various stakeholders and continually improve and refine our performance.


- 경제간접 기여성과
- 고용, 납세, 배당 등 기업 활동이 경제에 기여하는 가치
- 환경성과
- 친환경 제품 개발 및 생산, 제품 생산 공정에 따른 환경 영향의 (-) 가치
- 사회성과
- 제품을 통한 삶의 질 개선, 노동 환경 개선 및 동반성장 활동, 지역사회공헌 활동으로 창출한 가치
Indirect Economic Contribution
Through the business activities, SK bioscience not only generates economic performance for itself but also makes an indirect contribution to the overall economy.


- 2022년
- 고용:1,009 억원
- 배당:0억원
- 납세:269억원
- 총 1,278 억원
- 2023년
- 고용:1,067억원
- 배당:0억원
- 납세:23억원
- 총 1,090억원
Environmental Performance
SK bioscience strives to minimize the environmental impacts of the vaccines throughout the entire process of R&D, production, and distribution. We will regularly measure and monitor our environmental performance to continually improve it.


- 2022년
- 환경(제품):0 억원
- 환경(공정):-2억원
- 총 -2 억원
- 2023년
- 환경(제품):0억원
- 환경(공정):-2억원
- 총 -2억원
Social Performance
SK bioscience creates social performance by improving the health of customers through vaccines, pursuing the happiness of stakeholders such as employees, and contributing to local communities through corporate philanthropic activities. We are enhancing our capabilities for optimized vaccine research and production through strengthening collaboration with global research institutions and building the Songdo Global R&PD Center, and we aim to take the lead in solving social issues in the medical and health fields. Looking ahead, we will continue to create social value linked to our business by fostering global bio talent who will join us in preparing for the next pandemic.


- 2022년
- 사회(삶의 질):384 억원
- 사회(노동):8억원
- 사회(동반성장):0억원
- 사회 공헌:83억원
- 총 445 억원
- 2023년
- 사회(삶의 질):497 억원
- 사회(노동):21억원
- 사회(동반성장):0억원
- 사회 공헌:36억원
- 총 554 억원
IDT Biologika ESG Management
ESG Management Framework & Performance
Under the ESG vision, IDT Biologika (hereinafter IDT) set the following vision and strategy and put an arduous effort to meet the highest environmental, social, and governance standards.
ESG Vision
‘With our economically, ecologically and socially responsible actions, we aim to improve quality of life for people and secure the livelihoods of the present generation and those to come.’
ESG Strategy


IDT commits to apply energy saving measures as well as a sustainable procurement to minimize environmental impacts by maintaining ISO 50001 Energy Management Certification, expanding its own power generation using photovoltaic systems, etc. Also IDT aims to provide their talented workforce with a healthy, safe, and diverse working environment, fair compensation and opportunities for growth and development. Also, IDT’s corporate governance established a transparent organizational structure and accountability system. The Compliance-based Management System (CMS), Business Continuity Management (BCM) and the Information Security Management System (ISMS) are those elements of IDT’s sustainable corporate governance.
As a member of the United Nations Global Compact, IDT upholds the UN Guiding principles on Business and Human Rights and supports the global goals in the areas of human rights, labor, environment, and anti-corruption. As an acknowledgement of its above efforts, IDT has been awarded the EcoVadis Gold Medal 2024 and EUPD Research’s ESG Transparency Award– for the sustainability measures undertaken in the field of environment, employment and human rights, ethics, and sustainable procurement.

ESG Ratings

Global Initiative Membership